Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma LSE:AMYT London Ordinary Share GB00BDD1LS57 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 20.25p 20.00p 20.50p 20.50p 20.15p 20.25p 124,784 14:00:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 1.2 -6.7 -4.1 - 43.91

Amryt Pharma (AMYT) Latest News

More Amryt Pharma News
Amryt Pharma Takeover Rumours

Amryt Pharma (AMYT) Share Charts

1 Year Amryt Pharma Chart

1 Year Amryt Pharma Chart

1 Month Amryt Pharma Chart

1 Month Amryt Pharma Chart

Intraday Amryt Pharma Chart

Intraday Amryt Pharma Chart

Amryt Pharma (AMYT) Discussions and Chat

Amryt Pharma Forums and Chat

Date Time Title Posts
14/1/201814:12Amryt Pharma2,035
27/3/201707:19Amryt Pharma108
21/4/201609:07AMYT1
21/4/201609:04Amryt Pharma2

Add a New Thread

Amryt Pharma (AMYT) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2018-01-16 17:10:3620.252,500506.25O
2018-01-16 15:31:1920.182,000403.60O
2018-01-16 15:28:0220.203,000605.93O
2018-01-16 14:20:5020.035,0001,001.25O
2018-01-16 14:17:5020.0018,7843,756.80O
View all Amryt Pharma trades in real-time

Amryt Pharma (AMYT) Top Chat Posts

DateSubject
16/1/2018
08:20
Amryt Pharma Daily Update: Amryt Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker AMYT. The last closing price for Amryt Pharma was 20.25p.
Amryt Pharma has a 4 week average price of 19.25p and a 12 week average price of 17.25p.
The 1 year high share price is 28.75p while the 1 year low share price is currently 16.75p.
There are currently 216,839,632 shares in issue and the average daily traded volume is 355,119 shares. The market capitalisation of Amryt Pharma is £43,910,025.48.
13/1/2018
11:39
greendragon777: Thanks DS, it would be great if they came out as soon as that. It would mean the countdown is about 6 weeks or less from now! 👍 I better get my on skates on with my remaining top up! 😁 It would be nice to have a few more distribution deals done with Lojuxta to help underpin AMYT's share price in the event of a negative result. Or another Lojuxta type licensing deal in itself would be great. The next few months are going to be very interesting indeed!
12/1/2018
12:03
greendragon777: That's fair enough JS, a profit is a profit nothing wrong with that. Take your money and run or forever hold your peace though. we are still invested here and I'm pretty sure everyone here who is still invested are going to see this investment through to the end (or at least the interim trial results). As Paps said, you may very well get an opportunity to buy in even below the low teens if the results are not in our favour, but until this happens what's the point of you even posting here? Ooops, sorry about the beeping noise in the background.....that's just an alert going off on my phone that AMYT's share price is going up! :-)
12/12/2017
17:09
papillon: Bronxville Posts: 62 Off Topic Opinion: No Opinion Price: 20.125 RE: Wiley,Nealon Today 15:50 Yep the market is on to the sleezy antics of this management team. Options should have been at .30 cents.. Wiley basically just gave himself a £400 thousand bonus! For What? >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> How has Wiley given himself a £400k bonus, Bronxville? Stop spouting unadultered rubbish. He HASN'T been given 2.061m shares. He's been given OPTIONS to acquire 2.061m shares. BIG DIFFERENCE. For all we know the AMYT share price will stay below the 20.12p subscription price (hope it doesn't, LOL) in which case he wont ever exercise that option to buy. This is AIM and AMYT still has a £55m Mkt Cap. There is NO guarantee that AP101 will be successful and there is NO guarantee that those who know how the phase 3 trial is progressing wont take advantage of that knowledge by selling, shorting, in the market. Not saying that will happen, but hey, who knows? I'm not against options per se, but the option price should have been much higher than the actual 20.12p. Perhaps 40p. That would have been an incentive. EDIT: For your information, Bronxville, Wiley will have received a £400k bonus from the BoD if the AMYT share price reaches 40p. Will it? Who can tell? I hope so, but I wouldn't bet my house on it happening. This is AIM after all and AMYT is very spculative. I've had a £4k gamble on AMYT, which I might push up to a maximum of £5k, but that's not definite. I definitely wouldn't go above £5k. I'm not rich enough to gamble more than £5k; after all I wouldn't bet £5k on a horse race, but some do!
14/11/2017
16:54
papillon: Bronxville Posts: 21 Off Topic Opinion: No Opinion Price: 18.125 RE: Slide Today 15:12 Management are a disgrace... I have never seen so many rookie mistakes starting with the share price drop from .24 in the original reverse merger.Not to mention blatently misleading shareholders on companies valuation. Ineptitude!! >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> LOL. LOL. Bronxville is the disgrace! Management are doing their job. The share price is dictated by short term traders! The job of management is to open up new markets for Lojuxta and progress the trials for AP101 & AP102. They seem to be doing that. Investors, especially short term traders, dictate the share price!!!!!!!!!! Obviously the recent placing was bad news for the AMYT share price in the short term. Why the BoD decided that the time was right to raise more cash is open to question. I don't think it affects AMYT prospects in the medium & longer term; Lojuxta sales and the trial results will determine the AMYT share price in the medium & longer term.
21/9/2017
15:57
greendragon777: I don't know folks am I reading this wrong or is the share price holding up extremely well considering a 25% dilution? If it holds at current levels I will be very happy. With regards to holding off until next year for the placing, the directors will be looked upon as absolute heros if the stock markets took a turn and all companies similar to AMYT get completely locked out of the markets for funding! I think if you take a long term view on AMYT there is so much upside and I wouldn't be trying to trade a 10% or 20% gain here and thee when there is a possible (and looking increasingly likely) uplift in the '00s and maybe even the '000s of percent! :-) A quick remeinder of those words of wisdom from Warren Buffett himself....."The stock market is an efficient place where money is transferred from the impatient to the patient" :-) Hold onto your AMYT shares for dear life folks or forever hold your peace! haha
15/9/2017
12:13
diamondstar1: Good points raised paps about premiums! Yes, I appreciate this point. Here's another one to consider.. First-to-market vs. Second-to-market. For quite a while, Episalvan was projected to be second-to-market, and Zorbrisa first-to-market. Assuming that there was no clinical differentiators between the 2 ie, efficacy & safety similar (which most people would assume as 'base case'), the standard marketing models would suggest that Episalvan should achieve about 1/5th the sales of Zorbrisa. Therefore, if the 'market valuation' of Scioderm was USD$229 million/£168 million (ie, the upfront payment Amicus paid) - then Amryt 'market valuation' should be circa £33.6. In fact, when Amryt share price was 14p, it's market cap was £28 million. When more recently the share price was 20p, the market cap was £40 million. So, in actual fact, market valuation has not departed greatly from the £33.6 million level. However, more recently, when the Zorbrisa demise came, this effectively becomes a 'game-changer' for Amryt/Episalvan. Valuation should be around the level of Scioderm. Yes, we can apply some 'discount factor' or 'reduction in premium', in order to make this valuation more conservative. But suddenly, being potentially first-to-market will make a huge difference for Amryt. Investors and analysts will hopefully wake up to this fact.
03/7/2017
14:49
papillon: An example of what bad news can do to a share price is UJO today. The share price has been quite bullish, on good volume, over the last few days, in anticipation of a good result from a N. Lincclnshire planning application, but bad news has just been issued and the UJO share price has collapsed! Confirmation, if any was needed, that news drives share prices.
01/3/2017
11:37
gnnmartin: papillon, I've long ben intrigued by strange reported trades: trades of 1 share being the obvious example. Having read Flash Boys, I wonder if it is automatic trading software, though I don't really expect bots to be interested in small cap shares: at least, the bots that Flash Boys talks about were (IIUC) only interested in shares that trade in five figure dollar amounts. The starting point for designing a bot program is much like chart based trading: look at the recent trades and decide which way the share price is going to move, but whereas the chartist is interested in movement over the next days to months the bot is interested in movement over the next seconds to minutes. In the case of Flash Boys, the bot is interested in the movement over the next few microseconds. However, pseudo charting is just the starting point. Much like the game of 'paper, scissors, stone', or indeed like poker, the bot hopes to work out what other traders intend to do by studying what they have recently done. Naturally, bots will then take steps to ensure that other bots (and human traders) don't twig what the bot intends, or even are positively misled as to the bots intentions. Humans can do the same: as did that guy from London who made millions trading on Nasdaq and has just lost his fight to avoid extradition to the USA where he faces charges of distorting the market. The moral is that it is dangerous to make too much money on the USA market even if you are only using the same trading techniques as the big boys are using in the USA. In the USA (metaphorically speaking) poker games often end in gun fights. So, why the single share trades? Obviously this has to be done by a bot (or person) that pays millipence per trade, which rules out me! But I guess that there are some bots that look at the number of trades in the last hour (say), or look at the average price of the last 5 deals (again, I'm trying to imagine something fairly believable, nothing more accurate than that). In this case the bot that is placing the single share trades reckons that some other bot or bots might be interested in that security and wants to 'paint a picture' (as Tom Wolfe put it, in Bonfire of the Vanities). The pictures are not necessarily only aimed at other bots. People tend to look at closing prices and the movement reported during the day, or at some automatic report of closing/opening/current price, and the various media use different ways of reporting. You have probably noticed that ADVFN, LSE, III, and other can sometimes report quite different data for closing prices, current movement, and so forth. A bot that posts 5 trades of one share might be aimed at influencing one or more of these data channels. It's a bit like the ways that city boys nudged the LIBOR (etc.) rates by reporting phoney interest in loans. As ever, the line between clever negotiating and dishonest trading is blurred, and the clever negotiator who is too successful is liable to find him (or her) self described as dishonest. One oddity that blossomed recently is the reported trade that is deleted and then immediately re-instated. For example, a trade of £10,000 at 10p per share might be deleted and immediately re-instated some hours or even a day later, by which time 10p lies well outside the current quoted spread. The honest reason for deleting and reinstating a trade is that you failed to mention that there were bargain conditions attached (say), or you got the bargain price wrong, or the quantity, or such like, but in almost all, perhaps all, examples I have noticed, the trade deleted is then reposted without any change. I notice that some media channels report the number of shares traded and fail to count a deleted trade as positive. If (for example) 100,000 shares are reported as traded at 10p at 8:00, and then at 12:00 it is reported that at 8:00 100,000 shares were wrongly marked as traded at 10p, and then at 12:01 it is reported that at 8:00 100,000 shares were traded at 10p, then some data streams add 300,000 shares to their tally of trades during the day, giving a false impression of trading activity. I expect too that some people (or bots) will get a false impression of the current share price when a big trade is posted at what is in effect an old price. I could go on, but I guess that is more than enough for something fairly off thread. All guesswork.
04/11/2016
16:22
papillon: It's proving to be a very slow death for the AMYT share price in the continuing absence of good news (in fact any news!) from the company. I seem to remember the intraday low was around 14-14.25p back in early July. Will a retest of that low encourage bottom fishing buyers again, or will the AMYT share price continue it's descent into oblivion? Answers on a postcard please! LOL. Is AMYT worth a bottom fishing buy I wonder when it's below 15p?
19/8/2016
18:29
papillon: dingo75 16 Aug'16 - 13:26 - 295 of 302 1 0 papp lol egg on your FACE! >>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>> LOL. I'm always ending up with egg on my face, dingo75. However I still believe we will see a small, short term, fall back in the AMYT share price and then the formation of a bullish Inverse Head & Shoulders. You could be right and I will be proved wrong and end up with egg on my face, but I'm hopeful I will soon be proved right. After all a bullish chart formation, after a period of a falling share price, is often the sign that a significant price reversal and subsequent major share price rise is on the cards. Don't throw any more raw eggs at me just yet, dingo75, but keep them ready! LOL.
Amryt Pharma share price data is direct from the London Stock Exchange
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180117 05:14:55